Skip to main content
. 2024 Dec 18;17:124. doi: 10.1186/s13045-024-01650-6

Table 2.

Predictive biomarker studies presented at the 2024 ASCO meeting

Studies and references Histology Biomarkers Outcomes
LEOPARD [93] Localized osteosarcoma Detection of ctDNA Worse 2-year EFS (56 vs 88%)
Gillani et al. [99] Localized Ewing sarcoma Loss of STAG2 expression Higher rate of relapse
Denu et al. [102] uLMS, DDLPS, UPS Loss of ATRX expression Worse OS

EFS event-free survival; uLMS uterine leiomyosarcoma